PT3818078T - Métodos de produção de proteínas recombinantes - Google Patents
Métodos de produção de proteínas recombinantesInfo
- Publication number
- PT3818078T PT3818078T PT197458458T PT19745845T PT3818078T PT 3818078 T PT3818078 T PT 3818078T PT 197458458 T PT197458458 T PT 197458458T PT 19745845 T PT19745845 T PT 19745845T PT 3818078 T PT3818078 T PT 3818078T
- Authority
- PT
- Portugal
- Prior art keywords
- methods
- recombinant proteins
- producing recombinant
- producing
- proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862693606P | 2018-07-03 | 2018-07-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3818078T true PT3818078T (pt) | 2024-04-18 |
Family
ID=67470657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT197458458T PT3818078T (pt) | 2018-07-03 | 2019-07-02 | Métodos de produção de proteínas recombinantes |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US20210253996A1 (https=) |
| EP (2) | EP3818078B1 (https=) |
| JP (3) | JP7419273B2 (https=) |
| KR (2) | KR20250153311A (https=) |
| CN (1) | CN112839954A (https=) |
| AU (1) | AU2019299358B2 (https=) |
| CA (1) | CA3104684A1 (https=) |
| DK (1) | DK3818078T3 (https=) |
| EA (1) | EA202092904A1 (https=) |
| ES (1) | ES2976708T3 (https=) |
| FI (1) | FI3818078T3 (https=) |
| HR (1) | HRP20240584T1 (https=) |
| HU (1) | HUE066560T2 (https=) |
| IL (2) | IL324666A (https=) |
| LT (1) | LT3818078T (https=) |
| MX (1) | MX2020013633A (https=) |
| PL (1) | PL3818078T3 (https=) |
| PT (1) | PT3818078T (https=) |
| RS (1) | RS65472B1 (https=) |
| SG (1) | SG11202012582QA (https=) |
| SI (1) | SI3818078T1 (https=) |
| SM (1) | SMT202400173T1 (https=) |
| WO (1) | WO2020010080A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK181991B1 (en) * | 2021-11-11 | 2025-05-15 | Dsm Ip Assets Bv | Combined fermentation process for producing one or more human milk oligosaccharide(s) (hmo(s)) in escherichia coli |
| JP2025520392A (ja) * | 2022-06-15 | 2025-07-03 | ユーシービー バイオファルマ エスアールエル | 細胞培養プロセス |
| EP4339274B1 (en) | 2022-09-13 | 2025-03-26 | Sartorius Stedim Biotech GmbH | Method for operating a bioprocess installation for production of a bioproduct |
| KR20240172522A (ko) * | 2023-06-01 | 2024-12-10 | (주)알테오젠 | 지속형 호르몬 수용체 길항제의 생산 방법 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4515893A (en) | 1979-04-26 | 1985-05-07 | Ortho Pharmaceutical Corporation | Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells |
| US5672347A (en) | 1984-07-05 | 1997-09-30 | Genentech, Inc. | Tumor necrosis factor antagonists and their use |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| US5091313A (en) | 1988-08-05 | 1992-02-25 | Tanox Biosystems, Inc. | Antigenic epitopes of IgE present on B cell but not basophil surface |
| US5720937A (en) | 1988-01-12 | 1998-02-24 | Genentech, Inc. | In vivo tumor detection assay |
| EP0420937B1 (en) | 1988-06-21 | 1994-11-09 | Genentech, Inc. | Therapeutic compositions for the treatment of myocardial infarction |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| CA2113813C (en) | 1991-08-14 | 2005-04-12 | Paula M. Jardieu | Immunoglobulin variants for specific fc epsilon receptors |
| WO1994004188A1 (en) | 1992-08-21 | 1994-03-03 | Genentech, Inc. | Method for treating an lfa-1-mediated disorder |
| US5736137A (en) | 1992-11-13 | 1998-04-07 | Idec Pharmaceuticals Corporation | Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| DK0733207T3 (da) | 1993-12-10 | 1998-04-20 | Genentech Inc | Fremgangsmåder til diagnose af allergi og screening af anti-allergi-terapeutika |
| DK0739214T3 (da) | 1994-01-18 | 1998-10-07 | Genentech Inc | Fremgangsmåde til behandling af parasitinfektionerunder anvendelse af IgE antagonister |
| US5702946A (en) | 1994-03-03 | 1997-12-30 | Genentech, Inc. | Anti-IL-8 monoclonal antibodies for treatment of inflammatory disorders |
| IL117645A (en) | 1995-03-30 | 2005-08-31 | Genentech Inc | Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration |
| AU6267896A (en) | 1995-06-07 | 1996-12-30 | Imclone Systems Incorporated | Antibody and antibody fragments for inhibiting the growth oftumors |
| IL125255A (en) | 1996-01-23 | 2002-02-10 | Genentech Inc | Anti-cd18 antibodies for treating stroke |
| US7147851B1 (en) | 1996-08-15 | 2006-12-12 | Millennium Pharmaceuticals, Inc. | Humanized immunoglobulin reactive with α4β7 integrin |
| WO1998023761A1 (en) | 1996-11-27 | 1998-06-04 | Genentech, Inc. | HUMANIZED ANTI-CD11a ANTIBODIES |
| JP3957765B2 (ja) | 1997-04-07 | 2007-08-15 | ジェネンテク・インコーポレイテッド | 抗ｖｅｇｆ抗体 |
| EP0981618B2 (en) | 1997-05-15 | 2011-08-24 | Genentech, Inc. | Anti-apo-2 antibody |
| US6946129B1 (en) | 1999-06-08 | 2005-09-20 | Seattle Genetics, Inc. | Recombinant anti-CD40 antibody and uses thereof |
| AU778199B2 (en) | 1999-10-29 | 2004-11-25 | Genentech Inc. | Anti-prostate stem cell antigen (PSCA) antibody compositions and methods of use |
| TWI374935B (en) * | 2004-08-27 | 2012-10-21 | Pfizer Ireland Pharmaceuticals | Production of α-abeta |
| TWI456062B (zh) * | 2006-09-13 | 2014-10-11 | Abbvie Inc | 細胞培養改良 |
| EP2673296B1 (en) | 2011-02-07 | 2018-10-24 | Cerenis Therapeutics Holding SA | Lipoprotein complexes and manufacturing and uses thereof |
| DK2726600T3 (en) * | 2011-07-01 | 2017-05-15 | Amgen Inc | Mammalian Cell Culture |
| DK3083933T3 (da) * | 2013-12-20 | 2026-03-16 | Biogen Ma Inc | Anvendelse af perfusionssåningskulturer til forbedring af biofarmaceutisk fed-batch-produktionskapacitet og -produktkvalitet |
| JP2017516484A (ja) * | 2014-06-03 | 2017-06-22 | ルピン・リミテッド | タンパク質生産のための細胞培養工程 |
| PT3152317T (pt) * | 2014-06-04 | 2019-04-18 | Amgen Inc | Métodos de colheita de culturas de células de mamíferos |
| WO2015198451A1 (ja) | 2014-06-26 | 2015-12-30 | 楽天株式会社 | 情報処理装置、情報処理方法及び情報処理プログラム |
-
2019
- 2019-07-02 EP EP19745845.8A patent/EP3818078B1/en active Active
- 2019-07-02 EP EP24153543.4A patent/EP4368699A3/en active Pending
- 2019-07-02 RS RS20240475A patent/RS65472B1/sr unknown
- 2019-07-02 SG SG11202012582QA patent/SG11202012582QA/en unknown
- 2019-07-02 IL IL324666A patent/IL324666A/en unknown
- 2019-07-02 US US17/252,163 patent/US20210253996A1/en active Pending
- 2019-07-02 PL PL19745845.8T patent/PL3818078T3/pl unknown
- 2019-07-02 CA CA3104684A patent/CA3104684A1/en active Pending
- 2019-07-02 HU HUE19745845A patent/HUE066560T2/hu unknown
- 2019-07-02 AU AU2019299358A patent/AU2019299358B2/en active Active
- 2019-07-02 LT LTEPPCT/US2019/040298T patent/LT3818078T/lt unknown
- 2019-07-02 ES ES19745845T patent/ES2976708T3/es active Active
- 2019-07-02 PT PT197458458T patent/PT3818078T/pt unknown
- 2019-07-02 HR HRP20240584TT patent/HRP20240584T1/hr unknown
- 2019-07-02 KR KR1020257033442A patent/KR20250153311A/ko active Pending
- 2019-07-02 SI SI201930722T patent/SI3818078T1/sl unknown
- 2019-07-02 CN CN201980044908.3A patent/CN112839954A/zh active Pending
- 2019-07-02 KR KR1020217003056A patent/KR102870511B1/ko active Active
- 2019-07-02 WO PCT/US2019/040298 patent/WO2020010080A1/en not_active Ceased
- 2019-07-02 MX MX2020013633A patent/MX2020013633A/es unknown
- 2019-07-02 DK DK19745845.8T patent/DK3818078T3/da active
- 2019-07-02 FI FIEP19745845.8T patent/FI3818078T3/fi active
- 2019-07-02 JP JP2020573229A patent/JP7419273B2/ja active Active
- 2019-07-02 SM SM20240173T patent/SMT202400173T1/it unknown
- 2019-07-02 EA EA202092904A patent/EA202092904A1/ru unknown
-
2020
- 2020-12-25 IL IL279782A patent/IL279782B1/en unknown
-
2024
- 2024-01-10 JP JP2024001657A patent/JP2024050590A/ja active Pending
-
2025
- 2025-01-17 US US19/030,272 patent/US20250171732A1/en active Pending
- 2025-12-12 JP JP2025247705A patent/JP2026048825A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL288205A (en) | Purification of fkpa and its uses for the production of recombinant polypeptides | |
| SG11202104136YA (en) | Heterodimeric fc-fused proteins | |
| ZA202006604B (en) | Method for selection of high m6p recombinant proteins | |
| ZA201903356B (en) | Novel polypeptide and method of producing imp using the same | |
| GB201419109D0 (en) | Incorporation of unnatural amino acids into proteins | |
| IL286745A (en) | Continuous production of recombinant proteins | |
| EP3236772A4 (en) | Methods of purifying recombinant proteins | |
| IL276067A (en) | Production of glucagon peptides | |
| MA53498A (fr) | Production de protéines recombinantes | |
| IL284026A (en) | Methods for producing heterodimeric antibodies | |
| IL286475A (en) | Methods for the manufacture of recombinant viral vectors | |
| GB201806072D0 (en) | Methods of manufacture | |
| SG11202012582QA (en) | Methods of producing recombinant proteins | |
| ZA202101433B (en) | An improved process for the preparation of recombinant lectin protein | |
| IL262875B (en) | Methods of regulation of galactosylation profiles of recombinant proteins | |
| EP3377633C0 (en) | PRODUCTION OF RECOMBINANT PROTEINS | |
| IL262544A (en) | A method for producing a recombinant protein | |
| GB201805904D0 (en) | Methods of Manufacture | |
| IL291618A (en) | Heterodimeric proteins | |
| EP3532618A4 (en) | SIGNAL POLYPEPTIDES FOR IMPROVED PROTEIN SECRETION | |
| SG11202107697UA (en) | Method for producing recombinant protein | |
| IL262781A (en) | Methods for reducing trisulfide bonds during recombinant production of polypeptides | |
| SG11201708751RA (en) | Method of producing a recombinant protein | |
| EP3289092A4 (en) | Methods of manufacturing therapeutic proteins | |
| IL265297A (en) | Methods for regulating production profiles of recombinant proteins |